| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22K | — | +175.0% |
| Cost of Revenue | $97K | — | +169.4% |
| R&D Expense | $1.4M | — | +76.4% |
| SG&A Expense | $6.4M | — | +45.0% |
| Operating Income | -$8.0M | — | -47.5% |
| Pre-tax Income | -$1.1M | — | -105.7% |
| Income Tax | $0 | — | — |
| Net Income | -$60K | — | -100.3% |
| EPS (Basic) | -$4.42 | — | -445.3% |
| EPS (Diluted) | -$4.42 | — | -1400.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.5M | +320.0% | — |
| Accounts Receivable | $21K | +40.0% | +133.3% |
| Current Assets | $7.4M | +189.9% | +103.8% |
| Total Assets | $45.4M | +17.0% | -14.0% |
| Current Liabilities | $3.7M | -75.3% | -62.5% |
| Total Liabilities | $20.4M | +23.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | -65.7% |
| Capital Expenditures | $22K | — | +266.7% |
| Investing Cash Flow | -$22K | — | -266.7% |
| Financing Cash Flow | $7.6M | — | +143.8% |
| Free Cash Flow | -$2.6M | — | -66.5% |
| +71.8% |
| Stockholders' Equity | $39.5M | +16.4% | -12.2% |